AngioScore Inc., a Fremont, Calif.-based developer of angioplasty catheters for use in the treatment of coronary and peripheral artery disease, has raised $30 million in Series E funding. Telegraph Partners led the deal, and was joined by return backers Psilos Group Management, QuestMark Partners, UV Partners, California Technology Ventures and Innomed Ventures. Angioscore previously raised over $45 million in VC funding, including a $30 million Series D round last year at a post-money valuation of approximately $75 million. www.angioscore.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.